Kazia Therapeutics (KZIA) Return on Equity (2009 - 2025)

Kazia Therapeutics has reported Return on Equity for 14 years, with the latest figure at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Equity changed N/A year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed N/A YoY), and the FY2025 full-year result was 0.02%, up 27.0% from the prior year.
• Return on Equity for Q4 2025 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.0% in Q2 2024, with the low at 0.0% in Q4 2023.
• Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.0% in 2022.
• The largest YoY upside for Return on Equity was 0 bps in 2021 against a maximum downside of 0 bps in 2021.
• Kazia Therapeutics' Return on Equity stood at 0.0% in 2021, then tumbled by 131 bps to 0.0% in 2022, then slumped by 80 bps to 0.0% in 2023, then surged by 462 bps to 0.0% in 2024, then tumbled by 113 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q4 2025), 0.0% (Q2 2024), and 0.0% (Q4 2023), per Business Quant data.